Department of Pharmacy, is the first academic Laboratory of Pharmacogenomics and Individualized Therapy in Greece. Nowadays, although Pharmacogenomics is regarded as one of its most promising disciplines in modern medicine, it is barely covered by Greek Universities, while research and education in the field is limited. The Laboratory of Pharmacogenomics and Individualized Therapy aspires to fill in this gap, while setting an precedent for the establishment of corresponding laboratories in other Universities and Research Centers in the country.
Personalized medicine is the tailoring of medical treatment which can be described as providing “the right patient with the right drug at the right dose at the right time for each patient.
Pharmacogenomics is the study of individual’s genomic differences and the way that affect to drug response.
Immediate and optimal personalized treatment that bring about: -Avoid side effects -Better quality of life -Reduction of costs
PGx tests on drugs from various therapeutic categories, such as antidepressants, antipsychotics, cancer, cardiac, immunosuppressants (Citalopram, Escitalopram, Paroxetine, Sertaline, Venlaflaxine, Amitriptyline, Clomipramine, Doxepine, Imipramine, Nortryptiline, Aripiprazole, Clozapine, Haloperidol, Pimozide, Capecitabine, Fluorouracil, Tamoxifen, Irinotecan, Flecainide, Propafenon, Acenocoumarol, Clopidrogel, Phenprocoumon, Warfarin, Metoprolol, Tacrolimus), pharmacogenes (CYP2D6, CYP2C19, CYP1A2, CYP3A5, VKORC1, SLCO1B1, DPYD, UGT1A1) as well as their genomic biomarkers.
The Laboratory staff consists of 21 researchers, technicians, administrative staff, PhD students and postgraduate students and are spread into 4 different research groups. Also, our laboratory offers, on a regular basis, training opportunities to international students from various countries worldwide, which underlines its commitment to training and international research collaboration.